Skip to content

CVS HEALTH CORPORATION: 10-Q filed 2014-11-04

What CVS HEALTH CORPORATION reported in its quarterly report filed 2014-11-04 (fiscal Q3 2014): 41 published measures, 114 facts as tagged in accession 0000064803-14-000036.

This filing

Form
10-Q (quarterly report)
Filed
2014-11-04
Fiscal period
fiscal Q3 2014
Accession
0000064803-14-000036 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CVS HEALTH CORPORATION filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-09-3073,576,000,000USD
At 2013-12-3171,526,000,000USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-09-3038,104,000,000USD
At 2013-12-3137,938,000,000USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-09-301,132,000,000USD
At 2013-12-314,089,000,000USD
At 2013-09-301,505,000,000USD
At 2012-12-311,375,000,000USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2014-01-01 to 2014-09-304,714,000,000USD273
2013-01-01 to 2013-09-304,245,000,000USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2014-01-01 to 2014-09-301,436,000,000USD273
2013-01-01 to 2013-09-301,330,000,000USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2014-07-01 to 2014-09-3035,021,000,000USD92
2014-01-01 to 2014-09-30102,312,000,000USD273
2013-07-01 to 2013-09-3031,932,000,000USD92
2013-01-01 to 2013-09-3093,931,000,000USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2014-01-01 to 2014-09-30-4,133,000,000USD273
2013-01-01 to 2013-09-30-2,498,000,000USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2014-01-01 to 2014-09-30-3,534,000,000USD273
2013-01-01 to 2013-09-30-1,622,000,000USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-09-3030,845,000,000USD
At 2013-12-3128,493,000,000USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2014-07-01 to 2014-09-301,157,000,000shares92
2014-01-01 to 2014-09-301,167,000,000shares273
2013-07-01 to 2013-09-301,218,000,000shares92
2013-01-01 to 2013-09-301,226,000,000shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2014-07-01 to 2014-09-301,164,000,000shares92
2014-01-01 to 2014-09-301,175,000,000shares273
2013-07-01 to 2013-09-301,226,000,000shares92
2013-01-01 to 2013-09-301,234,000,000shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2014-07-01 to 2014-09-300.82USD/shares92
2014-01-01 to 2014-09-302.84USD/shares273
2013-07-01 to 2013-09-301.03USD/shares92
2013-01-01 to 2013-09-302.71USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2014-07-01 to 2014-09-300.81USD/shares92
2014-01-01 to 2014-09-302.82USD/shares273
2013-07-01 to 2013-09-301.02USD/shares92
2013-01-01 to 2013-09-302.7USD/shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2014-07-01 to 2014-09-30624,000,000USD92
2014-01-01 to 2014-09-302,165,000,000USD273
2013-07-01 to 2013-09-30777,000,000USD92
2013-01-01 to 2013-09-302,112,000,000USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-09-308,694,000,000USD
At 2013-12-318,615,000,000USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2014-01-01 to 2014-09-30121,000,000USD273
2013-01-01 to 2013-09-30101,000,000USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-07-01 to 2014-09-302,246,000,000USD92
2014-01-01 to 2014-09-306,478,000,000USD273
2013-07-01 to 2013-09-302,154,000,000USD92
2013-01-01 to 2013-09-305,820,000,000USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-09-3025,337,000,000USD
At 2013-12-3125,325,000,000USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2014-07-01 to 2014-09-30158,000,000USD92
2014-01-01 to 2014-09-30480,000,000USD273
2013-07-01 to 2013-09-30125,000,000USD92
2013-01-01 to 2013-09-30379,000,000USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-09-3018,213,000,000USD
At 2013-12-3115,425,000,000USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2014-09-306,033,000,000USD
At 2013-12-315,548,000,000USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2014-09-3028,151,000,000USD
At 2013-12-3126,542,000,000USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2014-09-3010,828,000,000USD
At 2013-12-318,729,000,000USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2014-01-01 to 2014-09-302,801,000,000USD273
2013-01-01 to 2013-09-302,272,000,000USD273

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-07-01 to 2014-09-304,222,000,000USD92
2014-01-01 to 2014-09-3012,256,000,000USD273
2013-07-01 to 2013-09-303,873,000,000USD92
2013-01-01 to 2013-09-3011,624,000,000USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2014-09-3011,613,000,000USD
At 2013-12-3111,045,000,000USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2014-07-01 to 2014-09-306,468,000,000USD92
2014-01-01 to 2014-09-3018,734,000,000USD273
2013-07-01 to 2013-09-306,027,000,000USD92
2013-01-01 to 2013-09-3017,444,000,000USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2014-07-01 to 2014-09-3028,553,000,000USD92
2014-01-01 to 2014-09-3083,578,000,000USD273
2013-07-01 to 2013-09-3025,905,000,000USD92
2013-01-01 to 2013-09-3076,487,000,000USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-09-301,153,000,000shares
At 2013-12-311,180,000,000shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2014-09-3030,310,000,000USD
At 2013-12-3129,777,000,000USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2014-09-30-160,000,000USD
At 2014-06-30-132,000,000USD
At 2013-12-31-149,000,000USD
At 2013-09-30-194,000,000USD
At 2013-06-30-198,000,000USD
At 2012-12-31-181,000,000USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2014-09-3038,109,000,000USD
At 2013-12-3137,938,000,000USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2014-09-309,854,000,000USD
At 2013-12-319,529,000,000USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-09-301,540,000,000USD
At 2013-12-311,515,000,000USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-09-301,494,000,000USD
At 2013-12-311,421,000,000USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2014-09-305,433,000,000USD
At 2013-12-314,768,000,000USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2014-07-01 to 2014-09-30948,000,000USD92
2014-01-01 to 2014-09-303,323,000,000USD273
2013-07-01 to 2013-09-301,249,000,000USD92
2013-01-01 to 2013-09-303,327,000,000USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2014-07-01 to 2014-09-30126,000,000USD92
2014-01-01 to 2014-09-30391,000,000USD273
2013-07-01 to 2013-09-30124,000,000USD92
2013-01-01 to 2013-09-30370,000,000USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-09-301,872,000,000USD273
2013-01-01 to 2013-09-301,518,000,000USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-09-30449,000,000USD273
2013-01-01 to 2013-09-3079,000,000USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-09-301,222,000,000USD273
2013-01-01 to 2013-09-30697,000,000USD273

Inspect the source

Entity
CVS HEALTH CORPORATION / CIK 0000064803
Captured
2026-09-19T14:49:22.382Z
SEC response SHA-256
5c08d55a669ee073f26bb7dc68826076bf640f0a2b5ac5b2161408f67f96e3ff

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000064803.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))